Menten AI
menten.ai
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018 in San Francisco, it generates candidate sequences and validates them in its own laboratory. The company focuses on peptide binders for targets that small molecules struggle to reach.
News
September 8, 2025 Menten AI Adds Quantum Computing to Develop New Drugs The startup, backed by Y Combinator among others, aims to develop biologics, or drugs made from organic rather than synthetic material Read more
The startup, backed by Y Combinator among others, aims to develop biologics, or drugs made from organic rather than synthetic material
Read more
Report
September 8, 2025 How Business Can Use Quantum Computing Right Now (Not 10 Years Into The Future) CEO of PCIS. Entrepreneur with a deep focus on technology. Helping companies strategize, innovate and grow. Read more
CEO of PCIS. Entrepreneur with a deep focus on technology. Helping companies strategize, innovate and grow.
Read more
Report
Menten AI Leverages AWS, AI, and Quantum Computing to Create New and Improved Drugs AWS Startups
Learn how Menten AI is leveraging AWS, AI, and quantum computing to transform drug discovery. Explore the future of personalized and improved medicine.
Read more
Report
September 8, 2025 Terramera Leads Collaborative Effort to Predict New COVID-19 Virus Strains With Machine Learning and AI Government backs joint project to avoid future pandemics with better forecasting and pre-design of effective vaccines, antibodies and tests Read more
Government backs joint project to avoid future pandemics with better forecasting and pre-design of effective vaccines, antibodies and tests
Read more
Report
Macrocyclic peptides: Aiming for the perfect fit
The hunt for drugs that are big enough to interact with proteins but small enough to negotiate cell membranes is coming full circle
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.